Borregaard ASA
OSE:BRG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
158
208.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Borregaard ASA
Borregaard ASA
Depreciation & Amortization
Borregaard ASA
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Borregaard ASA
OSE:BRG
|
Depreciation & Amortization
kr544m
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Elkem ASA
OSE:ELK
|
Depreciation & Amortization
kr2.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aqua Bio Technology ASA
OSE:ABTEC
|
Depreciation & Amortization
kr2.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
28%
|
|
|
C
|
Circa Group AS
OSE:CIRCA
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
M Vest Water AS
OSE:MVW
|
Depreciation & Amortization
kr2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Tekna Holding ASA
OSE:TEKNA
|
Depreciation & Amortization
CA$4.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Borregaard ASA
Glance View
Nestled in the lush landscapes of Norway, Borregaard ASA has meticulously carved out a distinctive niche for itself in the world of biorefinery. Emerging from its roots in traditional pulp and paper production, Borregaard has adeptly transformed itself into a global leader of advanced and sustainable biochemicals. The company's biorefinery operation skillfully harnesses the potential of wood as its raw material, extracting high-value lignin, cellulose, vanillin, and other specialty chemicals. This innovative approach enables Borregaard to capitalize on its ability to not only replace fossil-based products but also to create environmentally friendly solutions for a range of industries such as agriculture, construction, and pharmaceuticals. The firm's dedication to sustainability and specialization reflects a forward-looking mindset that aligns with evolving market demands and global environmental standards. Revenue at Borregaard flows predominantly from its divisions, all working in concert to sustain its diverse portfolio. The Performance Chemicals division, for example, primarily markets lignin-based products, which serve as vital ingredients in concrete admixtures and battery components. Meanwhile, the Specialty Cellulose division transforms cellulose into unique applications, ranging from food additives to cosmetics, and fuels the company's growth in diverse markets. Then there is the Fine Chemicals department, which refines vanillin for flavor and fragrance industries. The company's tactical orientation towards innovation and sustainable production not only ensures a steady stream of revenue but also galvanizes its standing as a beacon of environmental responsibility in the chemical industry. In sum, Borregaard's story is one of transformation and foresight, leveraging its expertise to craft a profitable model that harmonizes with the planet's ecological aspirations.
See Also
What is Borregaard ASA's Depreciation & Amortization?
Depreciation & Amortization
544m
NOK
Based on the financial report for Sep 30, 2024, Borregaard ASA's Depreciation & Amortization amounts to 544m NOK.
What is Borregaard ASA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
9%
Over the last year, the Depreciation & Amortization growth was 15%. The average annual Depreciation & Amortization growth rates for Borregaard ASA have been 8% over the past three years , 6% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
